Evidence map›Paper›PMID 42465737›Full record

ArticleFrontiers in immunology2026

Correction: Shared germline-biased plasmablast clonotypes shape early neutralizing antibody responses during acute Chikungunya virus infection.

Kritika Dixit, Kaustuv Nayak, Manpreet Kaur Saini, Sofia Qamar, Prashant Bajpai, Elluri Seetharami Reddy, Sahil Ameer, Vikas Dhar Dubey, Muneeb Pervez, Sagar Kohli and 20 more

Abstract readPublished Erratum
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors.

Kritika DixitICGEB-Emory Vaccine Program, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Kaustuv NayakICGEB-Emory Vaccine Program, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Manpreet Kaur SainiICGEB-Emory Vaccine Program, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Sofia QamarICGEB-Emory Vaccine Program, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Prashant BajpaiICGEB-Emory Vaccine Program, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Elluri Seetharami ReddyICGEB-Emory Vaccine Program, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Sahil AmeerICGEB-Emory Vaccine Program, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Vikas Dhar DubeyICGEB-Emory Vaccine Program, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Muneeb PervezICGEB-Emory Vaccine Program, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Sagar KohliICGEB-Emory Vaccine Program, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Kamalvishnu GottimukkalaICGEB-Emory Vaccine Program, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Shipra GuptaDepartment of Biotechnology, School of Chemical & Life Sciences, Jamia Hamdard, New Delhi, India.
Naushad KhanDepartment of Biotechnology, School of Chemical & Life Sciences, Jamia Hamdard, New Delhi, India.
Deepti MaheshwariICGEB-Emory Vaccine Program, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Nawaz Sm AkhtarICGEB-Emory Vaccine Program, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Yadya M ChawlaICGEB-Emory Vaccine Program, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Ramesh Chandra RaiICGEB-Emory Vaccine Program, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Rohit SagarDepartment of Biotechnology, School of Chemical & Life Sciences, Jamia Hamdard, New Delhi, India.
Mohammad IslamuddinDepartment of Biotechnology, School of Chemical & Life Sciences, Jamia Hamdard, New Delhi, India.
Wajihul Hasan KhanDepartment of Biotechnology, School of Chemical & Life Sciences, Jamia Hamdard, New Delhi, India.
Nimisha MishraVector-Borne Diseases, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Ashok Kumar PatelKusuma School of Biology Sciences, Indian Institute of Technology, New Delhi, India.
Sujatha SunilVector-Borne Diseases, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Rakesh LodhaDepartment of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Vineet JainDepartment of Medicine, Hamdard Institute of Medical Sciences and Research (HIMSR), New Delhi, India.
Pratima RayDepartment of Biotechnology, School of Chemical & Life Sciences, Jamia Hamdard, New Delhi, India.
Kaja Murali-KrishnaICGEB-Emory Vaccine Program, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Keshav SainiICGEB-Emory Vaccine Program, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Sanjeev KumarICGEB-Emory Vaccine Program, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Anmol ChandeleICGEB-Emory Vaccine Program, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.

Funding

Immune responses associated with severe disease in patients with primary dengue infectionR01AI186371 · NIAID · EMORY UNIVERSITY · PI MURALI KRISHNA KAJA, Mehul Shamal Suthar · 2024 to 2026
$1.7M
NIAID NIH HHS R01 AI186371
6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2026.1846926.].

Indexed as

acute viral infectionChikungunya virusgermline antibodieshuman monoclonal antibodiesmemory B cellsneutralizing antibodiesplasmablastssingle B cell analysis

Identifiers

PMID42465737
PMCPMC13374022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.